Page Venture Gallery Venture Gallery View startups founded from across the University of Chicago ecosystem in a range of industries. Welcome to the Venture Gallery! The Polsky Center provides “first look” and early...
News 3 Startups Awarded $200,000 Each to Build Out Teams, Launch Novel Products Flow Medical, Lismikro, and OrisDX each have been awarded a $200,000 co-investment from the George Shultz Innovation Fund to further develop their technologies. Managed by the Polsky Center for Entrepreneurship...
Event Exploring Careers in Biomedical Innovation May 9, 2025 Join us for an insightful panel discussion that delves into the diverse and dynamic world of biomedical innovation. This event will feature experts and leaders from various sectors, including startups,...
News UChicago Researchers Isolate Antibodies to Treat and Diagnosis COVID-19, Work to Protect Against Future Threats University of Chicago researchers have isolated SARS-CoV-2 monoclonal antibodies, which have the potential to both treat and diagnose COVID-19. Led by Patrick Wilson, a professor of medicine at the University...
Technology SARS-CoV-2 Monoclonal Antibodies Against Spike and Internal Proteins for Therapeutics and Diagnostics As of February 2021, there have been over 107 million cases and over 2 million deaths caused worldwide by the novel virus SARS-CoV-2. Few vaccination and treatment approaches are currently…
Technology Broadly Neutralizing Neuraminidase Antibodies for Prophylactic and Therapeutic Treatment of Influenza One of the weaknesses of current influenza vaccines is seasonable variability in efficacy, which is predominantly caused by escape mutations in the hemagglutinin (HA) antigen, the main target of the…
Technology Neutralizing Monoclonal Antibodies Against SARS-CoV-2 The landscape of SARS-CoV-2 is experiencing a novel development of viral variants harboring mutations that can escape even the most highly potent antibodies against the receptor binding domain. These variants…
Technology A Novel Class of Antibodies For The Development Of Universal Influenza Vaccines Influenza viruses remain a global health problem, with antigenically drifting seasonal viruses and the constant risk of zoonotic influenza virus spillovers into humans. Antibodies against the major surface glycoprotein hemagglutinin…
Program Collaboratorium Showcase your research, technology, or ideas and develop a better understanding of the next steps to pursue a business opportunity.
News Fall 2025 Collaboratorium Connects Researchers and Business Expertise Connecting researchers and scientists with business expertise, the Fall 2025 Collaboratorium will feature teams participating in the Polsky I-Corps program in addition to startups from other areas of the...
News Home Chef, Remote Year Founders Among Winners at EY’s Entrepreneur of the Year Awards Two notable Chicago startup founders were just given a big nod for their entrepreneurial endeavors. Patrick Vihtelic, founder and CEO of Home Chef, and Greg Caplan, founder and CEO of Remote Year,...
News Polsky Center Announces Autumn 2018 I-Corps Program Cohort The Polsky Center for Entrepreneurship and Innovation is pleased to announce the latest cohort of the Polsky I-Corps program, a 7-week highly-experiential program designed to empower UChicago scientists, researchers, and...
